Bills · HR 796
IN COMMITTEE· 119TH CONGRESS
House BillHR 796Telephone and wireless communicationAbortion
Second Chance for Moms Act
INTRO JAN 28· LAST ACTION JAN 28
READING
2MIN
COSPONSORS
13
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it significantly alters the information provided to women about mifepristone, a widely used medication for ending pregnancies. If passed, it would ensure that women receive a specific warning about the potential for "abortion pill reversal" directly on the drug's packaging and have a direct federal resource (the hotline) to connect them with related services. This could influence their decisions and access to care during a critical time.
Without this bill, such a warning label and a federally supported hotline specifically for "abortion pill reversal" services would not be required. The bill introduces a new layer of government involvement in providing information and referrals related to medication abortion, highlighting ongoing societal and medical debates surrounding abortion access and patient information.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires a warning label on mifepristone packaging stating that its abortifacient effects can be counteracted by natural progesterone, which can increase the chance of fetal survival.
This provision introduces new, specific medical information on drug packaging that could influence a patient's decision after taking the medication.
PROVISION 02
Mandates that the warning label include a statement that the American Society for Reproductive Medicine has determined natural progesterone is safe in the first trimester of pregnancy.
This provision highlights an endorsement from a specific medical society on the drug's warning label.
PROVISION 03
Establishes a 24-hour, 7-day-a-week toll-free hotline to provide support and information for women seeking to reverse the effects of mifepristone.
This creates a new federal resource specifically for women who wish to attempt to stop a medication abortion.
PROVISION 04
Specifies that the hotline can only make referrals to healthcare providers who offer abortion pill reversal services.
This provision ensures that referrals from the hotline are narrowly focused on a specific type of medical intervention.
PROVISION 05
Sets an effective date for the warning label requirement to begin 6 months after the date the bill becomes law.
This provides a clear timeframe for drug manufacturers to update their packaging to comply with the new requirements.
SPONSORSHIP
1 + 13
R· Illinois
YRS IN OFFICE
5
BILLS LED
36
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 13 IND 0
ACTION TIMELINE
2 EVENTSJAN 28
Introduced in House
JAN 28
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 796
Congress119th
StatusIn Committee
IntroducedJan 28, 2025
Last actionJan 28, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED JAN 28, 2025
House BillHR 796Telephone and wireless communicationAbortion
Second Chance for Moms Act
INTRODUCED JAN 28, 2025· LAST ACTION JAN 28, 2025
PASSAGE CHANCES
—%
READING
2 min
COSPONSORS
13
COMPLEXITY
Moderate
